Basophil FcɛRI histamine release parallels expression of Src-homology 2–containing inositol phosphatases in chronic idiopathic urticaria  Becky M. Vonakis,

Slides:



Advertisements
Similar presentations
Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions  Kathleen R. Bartemes, BA, Kate.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2  Natalija Novak, MD, Nihal Mete, MD, Caroline.
High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,
Margaretha A. Faber, MD, Vito Sabato, MD, Chris H
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Proximal signaling events in FcɛRI-mediated mast cell activation
Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema  Sabine Zeller, MSc, Claudio Rhyner, PhD, Norbert Meyer, MD, Peter.
Christopher L. Kepley, PhD, Bridget S. Wilson, PhD, Janet M
Stacie M. Jones, MD, Scott H. Sicherer, MD, A
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria  Marcus Maurer, MD, Allen Kaplan, MD, Karin Rosén, MD, PhD, Michael Holden,
Liping Xie, MD, John T. Schroeder, PhD, Jacqueline M
Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D
Histamine H2 receptor stimulation upregulates TH2 chemokine CCL17 production in human M2a macrophages  Susanne Mommert, PhD, Karl Gregor, MD, Kristine.
Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain— containing protein tyrosine phosphatase 1  Alison Taylor, PhD, Mübeccel.
Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk  Jun Ho Lee, PhD, Jie Wan Kim,
A mouse Fcγ-Fcε protein that inhibits mast cells through activation of FcγRIIB, SH2 domain–containing inositol phosphatase 1, and SH2 domain–containing.
Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-α  John T. Schroeder, PhD,
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF- β1–stimulated primary human fibroblasts  Xiuxia Zhou, PhD, Haizhen.
Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions  Maria José Torres, MD, PhD,
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria 
Elina Jerschow, MD, MSc, Robert Y. Lin, MD, MSc, Moira M
Peter M. Wolfgram, MD, David B. Allen, MD 
Loss of syk kinase during IgE-mediated stimulation of human basophils
David D. Tieu, MD, Anju T. Peters, MD, Roderick T
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema  Marek L.
Brent E. Palmer, PhD, Douglas G. Mack, PhD, Allison K
Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors  Donald W. MacGlashan, MD, PhD,
Donald W. MacGlashan, MD, PhD, Sarbjit S. Saini, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Src homology 2 domain–containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung  Sun-Young Oh, PhD,
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria  Thomas Gentinetta, MSc, Tatjana.
Karen C. Dannemiller, PhD, Janneane F. Gent, PhD, Brian P
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: Potential role of histamine in airway remodeling  Steffen Kunzmann,
John A. Eckman, MD, Patricia M
Jeffrey M. Harris, MD, PhD, Christopher R
Cockroach allergens: Coping with challenging complexity
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Association between specific timothy grass antigens and changes in TH1- and TH2-cell responses following specific immunotherapy  Véronique Schulten, PhD,
Sarbjit S. Saini, MDa, Jennifer J
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab  Donald W. MacGlashan,
Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE- independent secretion  Anja P. Bieneman, BS, Kristin L. Chichester,
Asifa K. Zaidi, PhD, Sarbjit S. Saini, MD, Donald W
Significant association of FcɛRIα promoter polymorphisms with aspirin-intolerant chronic urticaria  Jin-Sik Bae, MS, Seung-Hyun Kim, PhD, Young-Min Ye,
Liping Xie, MD, John T. Schroeder, PhD, Jacqueline M
Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study 
Measles and immunomodulation
William J. Sheehan, MD, Helen A
Macrolide antibiotics and asthma treatment
Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria  Ronit Confino-Cohen, MD, Dorit Aharoni,
Asthma: The past, future, environment, and costs
Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria  Sridharan Soundararajan, PhD, Yoko Kikuchi, DVM, Kusumam Joseph, PhD,
Lisa A. Beck, MD, Sarbjit Saini, MD 
The effects of gastric digestion on codfish allergenicity
Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease  Jaclyn Smith, MD, PhD, Emily Owen, MPhil, John Earis, MD,
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Presentation transcript:

Basophil FcɛRI histamine release parallels expression of Src-homology 2–containing inositol phosphatases in chronic idiopathic urticaria  Becky M. Vonakis, PhD, Kavitha Vasagar, MS, Scott P. Gibbons, BS, Laura Gober, MD, Patricia M. Sterba, BS, Hyeyoun Chang, BS, Sarbjit S. Saini, MD  Journal of Allergy and Clinical Immunology  Volume 119, Issue 2, Pages 441-448 (February 2007) DOI: 10.1016/j.jaci.2006.09.035 Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 A, Subjects with CIU have a bimodal distribution of basophil HR to an optimal dose of anti-IgE (0.1 μg/mL) compared with normal subjects. B, CIU NR had significant reductions in basophil anti-IgE dependent release compared with normal, CIU R, and cold urticaria subjects (∗P < .00001). FMLP-induced release differed significantly only between CIU NR and CIU R (∗∗P < .001). HrHRF response was tested in a smaller subset of donors (as indicated) and was not significantly different between subjects with CIU and normal subjects. C, Basophil HR was examined across a range of anti-IgE doses in normal donors and donors with CIU (∗P < .0002 CIU NR vs normal subjects and CIU R). D, HR is presented as a percent of the maximal response achieved (see Methods). Journal of Allergy and Clinical Immunology 2007 119, 441-448DOI: (10.1016/j.jaci.2006.09.035) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Expression of Syk, SHIP-1, and SHIP-2 protein in basophils from donors with CIU, donors with cold urticaria, and normal (Nor) donors. A, Representative immunoblots shows a Nor, 2 CIU R, and 2 CIU NR donors. The scanned values were normalized to the T-cell standard lysate (Std) and corrected for cell equivalents (bottom). The upper panel demonstrates the expected 72-kd band of Syk, and the middle panel the expected band of 145 kd for SHIP-1, whereas the lower panel reveals the expected 155-kd SHIP-2 protein band. B, Mean values of Syk protein expression were not different among donor types. C, Mean normalized values for expression of SHIP-1 and SHIP-2 protein. SHIP-1 expression is reduced in cold urticaria and CIU R (∗P < .05 vs normal; #P < .05 vs CIU NR). SHIP-2 expression is increased in CIU NR compared with normal subjects (∗P < 0.05) and CIU R (#P < .03). Error bars represent SEMs. Journal of Allergy and Clinical Immunology 2007 119, 441-448DOI: (10.1016/j.jaci.2006.09.035) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Expression of phosphoAkt in basophils from CIU NR, CIU R, and a normal donor. A, Basophil lysates were examined at the indicated time points after stimulation with anti-IgE (0.1-0.3 μg/mL) for the expression of phosphoAkt and Erk. B, Phosphorylated Akt (pAKT) expression normalized to ERK protein (anti-IgE 0.1 μg/mL, dashed lines; 0.3 μg/mL, solid lines). Immunoblot representative of 2 to 3 similar experiments. Journal of Allergy and Clinical Immunology 2007 119, 441-448DOI: (10.1016/j.jaci.2006.09.035) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions